Literature DB >> 25416666

Pathophysiology of resistant hypertension in chronic kidney disease.

Vito M Campese1.   

Abstract

Hypertension associated with chronic kidney diseases often is resistant to drug treatment. This review deals with two main aspects of the management of CKD patients with hypertension: the role of sodium/volume and the need for dietary salt restriction, as well as appropriate use of diuretics and what currently is called sequential nephron blockade; the second aspect that is addressed extensively in this review is the role of the sympathetic nervous system and the possible clinical use of renal denervation.

Entities:  

Keywords:  Hypertension; chronic kidney disease; renal denervation; sodium intake; sympathetic nervous system

Mesh：

Substances：

Year:  2014        PMID： 25416666     DOI： 10.1016/j.semnephrol.2014.08.011

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN： 0270-9295            Impact factor:   5.299


  9 in total

Review 1.  Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Angela Yee-Moon Wang; Robert Kalyesubula; Elke Schaeffner; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2022-09-14       Impact factor: 42.439

Review 2.  Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.

Authors:  Karl Fengler; Karl Philipp Rommel; Thomas Okon; Gerhard Schuler; Philipp Lurz
Journal:  World J Cardiol       Date:  2016-08-26

3.  Clinical risk assessment of patients with chronic kidney disease by using clinical data and multivariate models.

Authors:  Zewei Chen; Xin Zhang; Zhuoyong Zhang
Journal:  Int Urol Nephrol       Date:  2016-06-22       Impact factor: 2.370

Review 4.  Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question).

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Rossella Attini; Silvia Parisi; Federica Fassio; Valentina Loi; Martina Gerbino; Marilisa Biolcati; Antonello Pani; Tullia Todros
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

5.  Raising the Bar in Renal Sympathetic Denervation Research and Reporting.

Authors:  John Lee; J Rick Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-15       Impact factor: 3.738

6.  Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial.

Authors:  Amanda E Coleman; Scott A Brown; Anne M Traas; Lawrence Bryson; Tanja Zimmering; Alicia Zimmerman
Journal:  J Vet Intern Med       Date:  2019-03-09       Impact factor: 3.333

7.  Contribution of selected vasoactive systems to blood pressure regulation in two models of chronic kidney disease.

Authors:  N Drábková; S Hojná; J Zicha; I Vaněčková
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

8.  Relationship between the exposure to cumulative cardiovascular health behaviors and factors and chronic kidney disease-The Kailuan study.

Authors:  Jinhong Hou; Junjuan Li; Jinjie Huang; Chunhong Lu; Jing Zhou; Yang Liu; Shouling Wu; Fang Wei; Lihua Wang; Haiyan Chen; Haibo Yu; Zhe Wang; Aili Jiang
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

9.  Consensus paper on the evaluation and treatment of resistant hypertension by the Turkish Society of Cardiology.

Authors:  Asife Sahinarslan; Emine Gazi; Meryem Aktoz; Cigdem Ozkan; Gülay Ulusal Okyay; Ozgul Ucar Elalmis; Erdal Belen; Reviewers Atila Bitigen; Ulver Derici; Neslihan Bascil Tutuncu; Aylin Yildirir
Journal:  Anatol J Cardiol       Date:  2020-09       Impact factor: 1.596
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.